PSUF
IOVA icon

People's United Financial’s Iovance Biotherapeutics IOVA Stock Holding History

People's United Financial’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-19,413
Closed -$143K – 716
2017
Q2 		$143K Hold
19,413
– – ﹤0.01% 635
2017
Q1 		$145K Hold
19,413
– – 0.01% 621
2016
Q4 		$135K Buy
+19,413
New +$134K 0.01% 599

Other funds holding IOVA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

People's United Financial's IOVA Position: Q3 2017 in Review

People's United Financial sold out of Iovance Biotherapeutics (IOVA) in Q3 2017, closing a stake of 19,413 shares — an estimated $143K sold.

People's United Financial first reported a position in IOVA in Q4 2016 and held it in 3 quarters. The position peaked at $145K in Q1 2017. 85 funds tracked by Wall St. Rank hold IOVA as of Q3 2017.

  • People's United Financial reported no remaining Iovance Biotherapeutics position as of Q3 2017 after selling out during the quarter.
  • People's United Financial sold 19,413 Iovance Biotherapeutics shares in Q3 2017, an estimated $143K.
  • People's United Financial first reported a position in Iovance Biotherapeutics in Q4 2016 and held it in 3 quarters.
  • People's United Financial's Iovance Biotherapeutics position peaked at $145K in Q1 2017.
  • 85 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2017.

Based on People's United Financial's 13F filing for Q3 2017, filed 13 Nov 2017.